Skip to main content
logo
Canature Health Technology Co., Ltd. (SHE:300272)
China flag China · Delayed Price · Currency is CNY
5.09
+0.10 (2.00%)
Oct 26, 2026, 3:04 PM CST

SHE:300272 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-47.8456.0170.39132.4592.56104.86
Depreciation & Amortization
83.4589.6184.0676.9175.7652.12
Other Amortization
10.399.364.492.314.5711.6
Loss (Gain) From Sale of Assets
0.110.140.11-2.42-1.550.18
Asset Writedown & Restructuring Costs
0.160.090.080.0915.476.52
Loss (Gain) From Sale of Investments
52.5643.7122.46-5.13-3.74-35.38
Provision & Write-off of Bad Debts
2.672.881.262.360.552.78
Other Operating Activities
201.0794.9461.4845.5818.230.84
Change in Accounts Receivable
-3.8-3.74-8.07-4.7426.17-137.99
Change in Inventory
-47.05-45.69-13.162.38-37.84-65
Change in Accounts Payable
53.5653.9358.6662.6-39.9218.53
Change in Other Net Operating Assets
--18.631.640.30.47
Operating Cash Flow
304.42299.61292.05374.83155.44186.77
Operating Cash Flow Growth
11.54%2.59%-22.09%141.15%-16.78%33.00%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-106.29-144.72-130.86-80.24-94.58-71.29
Sale of Property, Plant & Equipment
17.5116.950.140.572.644.7
Cash Acquisitions
----07.06
Divestitures
----8.43-99.88
Investment in Securities
1.25117.35-178.76-262.1127.12-41.03
Other Investing Activities
45.650.15-5.010.16
Investing Cash Flow
-83.26-4.5-309.07-349.67-59.81-0.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,3561,1621,124518.85409.78
Total Debt Issued
1,6741,3561,1621,124518.85409.78
Long-Term Debt Repaid
--981.14-1,211-643.52-357.88-427.33
Lease Payments
-32.13-32.54-25.03-29.36-24.97-8.25
Total Debt Repaid
-1,386-981.14-1,211-643.52-357.88-427.33
Net Debt Issued (Repaid)
288.64375.19-49.08480.69160.97-17.55
Issuance of Common Stock
---44.69-2.29
Repurchase of Common Stock
-13.5--29.06--31.37-38
Common Dividends Paid
-100.76-132.57-182.2-78.16-69.87-40.86
Other Financing Activities
-262.96-65.71-11.67-16.94-28.75-2.49
Financing Cash Flow
-88.57176.91-272.01430.2930.98-96.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-44.08-14.8412.3420.4514.820.84
Net Cash Flow
88.5457.18-276.68475.9141.4390.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
198.12154.89161.19294.5960.85115.48
Free Cash Flow Growth
134.71%-3.91%-45.28%384.12%-47.30%18.70%
Free Cash Flow Margin
10.77%8.41%9.35%17.62%3.66%7.64%
Free Cash Flow Per Share
0.320.270.280.510.110.20
Levered Free Cash Flow
-124.09160.65165.73107.38107.21
Unlevered Free Cash Flow
-152.13186.8183.5117.91117.39
Free Cash Flow After Leases
166122.35136.16265.2335.88107.23

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
14.3860.4761.9745.2218.4219.91
Change in Working Capital
1.862.8747.72122.68-46.3813.25